Filing Details
- Accession Number:
- 0001140361-14-041113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-12 08:55:01
- Reporting Period:
- 2014-11-04
- Filing Date:
- 2014-11-12
- Accepted Time:
- 2014-11-12 08:55:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380956 | Robert Kramer | 2273 Research Blvd Suite 400 Rockville MD 20850 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-11-04 | 1,238 | $22.31 | 60,463 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-11-07 | 2,625 | $24.00 | 57,838 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer. Mr. Kramer's direct holdings include restricted stock units as well as shares acquired through private placement.